The Technical Analyst
Humana Inc [HUM]
Exchange: NYSE Sector: Healthcare Industry: Healthcare Plans
Humana Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.15% $324.14
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 39 059 mill |
| EPS: | 16.23 |
| P/E: | 19.97 |
| Earnings Date: | Aug 01, 2024 |
| SharesOutstanding: | 120.50 mill |
| Avg Daily Volume: | 1.621 mill |
| RATING 2024-05-08 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.29x |
| Company: PE 19.97 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.79x |
| Company: PE 19.97 | industry: PE 25.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 315.78 - 332.51 ( +/- 2.58%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-18 | Mcdonald William J. | Buy | 0 | |
| 2024-03-28 | Smith Brad D | Buy | 92 | Restricted Stock Units |
| 2024-03-28 | Feinberg David T | Buy | 51 | Restricted Stock Units |
| 2024-03-28 | Hilzinger Kurt J | Buy | 270 | Restricted Stock Units |
| 2024-03-28 | Renaudin George Ii | Buy | 8 | Phantom Stock Units |
| INSIDER POWER |
|---|
| 86.59 |
| Last 98 transactions |
| Buy: 291 262 | Sell: 21 234 |
Forecast:
16:00 - $324.13
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $324.13
Forecast 2: 16:00 - $324.13
Forecast 3: 16:00 - $324.13
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $324.14 (-0.15% ) |
| Volume | 1.006 mill |
| Avg. Vol. | 1.621 mill |
| % of Avg. Vol | 62.10 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For HUM
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
HUM
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Latest Press Releases
2024-05-02 16:15:00 - Press Release
Humana Inc. To Present At B Of A Securities Health Care Conference 2024
Louisville, ky.--(business wire)--humana inc. (nyse: hum) announced today that bruce d. broussard, chief executive officer, and susan m. diamond, chief financial officer, will make a presentation to investors at b of a securities health care conference on tuesday, may 14, 2024, at 8:00 a.m. pacific time. a live audio webcast of the presentation will be available via humana's investor relations page at humana.com. the company suggests webcast participants sign on approximately 15 minutes in adva.
2024-04-25 11:20:00 - Press Release
Humana Healthy Horizons Commits $500k To Improve Health Of Louisianians
Baton rouge, la.--(business wire)--humana healthy horizons commits $500,000 to improve the health of louisianians.
2024-04-24 06:30:00 - Press Release
Humana Reports First Quarter 2024 Financial Results; Affirms Full Year Adjusted 2024 Financial Guidance
Louisville, ky.--(business wire)--humana inc. (nyse: hum) today reported consolidated pretax results and net earnings per share (eps) for the quarter ended march 31, 2024 (1q24) versus the quarter ended march 31, 2023 (1q23) as noted in the tables below. consolidated income before income taxes and equity in net earnings (pretax results) in millions 1q24 (a) 1q23 (a) generally accepted accounting principles (gaap) $1,014 $1,614 amortization associated with identifiable intangibles 16 18 pu.
2024-04-23 09:00:00 - Press Release
Cohere Health And Humana Expand Prior Authorization Partnership, Adding Diagnostic Imaging And Sleep Services
New solutions elevate and expedite patient care with upstream moments of influence boston and louisville, ky. , april 23, 2024 /prnewswire/ -- cohere health , a recognized leader in clinical intelligence and prior authorization automation, announced that humana inc. (nyse: hum) will expand its use of cohere's prior authorization platform for diagnostic imaging and sleep services.
2024-04-18 06:30:00 - Press Release
Humana Board Declares Payment Of Quarterly Dividend To Stockholders
Louisville, ky--(business wire)--humana inc. (nyse: hum) announced today that its board of directors has declared a cash dividend to stockholders of $0.885 per share payable on july 26, 2024 to stockholders of record as of the close of business on june 28, 2024. about humana humana inc. is committed to putting health first – for our teammates, our customers, and our company. through our humana insurance services, and our centerwell health care services, we make it easier for the millions of peo.
Latest News
2024-05-03 10:46:13 - Zacks Investment Research
4 HMO Stocks to Watch Amid Persistent Industry Challenges
The Medical-HMO industry continues to witness an expanding customer base resulting from contract wins. However, high technology expenses and a shortage of medical personnel are a concern.
2024-05-01 10:01:05 - Zacks Investment Research
Investors Heavily Search Humana Inc. (HUM): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Humana (HUM). This makes it worthwhile to examine what the stock has in store.
2024-05-01 07:15:17 - MarketBeat
Humana Leaves Shareholders in Limbo on 2025 EPS Guidance
Health insurer Humana Inc. NYSE: HUM reported its Q1 2024 earnings report to a less dramatic reaction than it got from its Q4 2023 report, causing shares to tumble more than 13%. Investors are still reeling over its vastly lowered EPS guidance stretching out to 2025.
2024-04-30 06:15:00 - InvestorPlace
3 Dirt-Cheap Health Stocks to Buy on Weakness
Some of the managed care stocks have been beaten down quite badly in recent months, thanks in part to choppy industry dynamics. Indeed, swift policy shifts (lower Medicare rates), cybersecurity breaches and loftier medical costs will certainly cause quite a bit of industry-wide volatility.
2024-04-24 19:15:30 - The Motley Fool
Why Humana Stock Withered on Wednesday
The sell-off confirms that market players trade on future potential, not trailing results. The big insurer delivered an estimates-beating first quarter, but its profitability guidance left something to be desired.
2024-04-24 13:56:07 - Zacks Investment Research
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
2024-04-24 13:50:22 - Zacks Investment Research
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
2024-04-24 13:40:47 - Investopedia
Humana Pulls 2025 Earnings Guidance on Slowing Government Medicare Funding
Humana (HUM) shares fell more than 5% in intraday trading Wednesday after it pulled its 2025 adjusted earnings guidance due to slower government healthcare spending.
2024-04-24 12:49:09 - Seeking Alpha
Humana, Inc. (HUM) Q1 2024 Earnings Call Transcript
Humana, Inc. (NYSE:HUM ) Q1 2024 Earnings Conference Call April 24, 2024 9:00 AM ET Company Participants Lisa Stoner - VP, IR Bruce Broussard - CEO & Director James Rechtin - President & COO Susan Diamond - CFO Conference Call Participants Ann Hynes - Mizuho Securities Kevin Fischbeck - Bank of America Merrill Lynch Gary Taylor - TD Cowen Scott Fidel - Stephens Benjamin Hendrix - RBC Capital Markets Nathan Rich - Goldman Sachs Group Stephen Baxter - Wells Fargo Securities Lisa Gill - JPMorgan Chase & Co. Andrew Mok - Barclays Joshua Raskin - Nephron Research Justin Lake - Wolfe Research Lance Wilkes - Sanford C. Bernstein & Co. A.J.
2024-04-24 11:41:30 - Proactive Investors
Humana shares fall as medical insurer withdraws 2025 profit guidance
Humana (NYSE:HUM) shares fell after it pulled its 2025 profit guidance, reigniting investor concerns about the impact of rising medical costs on the insurer's bottom line. Humana (NYSE:HUM) in January downgraded its 2025 profit forecast from $37 per share to between $22 to $26 per share upon the expectation it would see a rise in medical claims as patients undergo non-urgent surgeries delayed due to the pandemic.